opinion
Funding overview for the pharmaceutical industry and outlook for 2020
March 2, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma
This article was originally published in the January/February 2020 issue of Pharmafocus.With the advent of a New Year, Michael Jewell, …
The world needs a better plan for cancer survival by 2030
September 30, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Roche, UN General Assembly, United Nations, feature, opinion, pharma
Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s …
Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?
October 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma
Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
The value of measuring biotech Board performance
October 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma
Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …
Are we prepared for the ‘real world’?
March 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing opinion, real world data, recruitment
Dr Dilruwan Chaminda Herath, Medical Director for Chiesi Group, discusses whether the lack of impetus to push for recruitment of …
